Showing results (1251-1260 of 1,297) with videos related to

Sort By:
Pageof 130
Diabetologia|May 10, 2020
Type 2 diabetes and HbA1c are independently associated with wider retinal arterioles: the Maastricht studyWenjie Li, Miranda T Schram, Tos T J M Berendschot, et al.
Cell|March 19, 2021
Simultaneous binding of Guidance Cues NET1 and RGM blocks extracellular NEO1 signalingRoss A Robinson, Samuel C Griffiths, Lieke L van de Haar, et al.
Annals of the Rheumatic Diseases|July 7, 2019
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseasesNienke M Ter Haar, Charlotte Eijkelboom, Luca Cantarini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2024
ESMO Recommendations on clinical reporting of genomic test results for solid cancersJ van de Haar, P Roepman, F Andre, et al.
The Journal of Molecular Diagnostics : JMD|June 25, 2018
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor TissueMarthe M de Jonge, Dina Ruano, Ronald van Eijk, et al.
Annals of Work Exposures and Health|February 19, 2022
Response Letter to Koivisto et al. 'Evaluating the Theoretical Background of STOFFENMANAGER® and the Advanced REACH Tool'Wouter Fransman, Mario Arnone, Francesca Borghi, et al.
Science Translational Medicine|October 11, 2019
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patientsSalo N Ooft, Fleur Weeber, Krijn K Dijkstra, et al.
Annals of the Rheumatic Diseases|July 4, 2012
Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature reviewNienke Ter Haar, Helen Lachmann, Seza Özen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 24, 2016
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever RegistryNienke M Ter Haar, Jerold Jeyaratnam, Helen J Lachmann, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 20, 2023
Recombinant Interleukin-1 Receptor Antagonist Is an Effective First-Line Treatment Strategy in New-Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA-DRB1 Background and IL1RN VariantsRemco G A Erkens, Jorg J A Calis, Anouk Verwoerd, et al.
Pageof 130